Literature DB >> 16979895

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents.

Ken-ichi Yoshida1, Kiyoshi Nakayama, Yoshihiro Yokomizo, Masami Ohtsuka, Makoto Takemura, Kazuki Hoshino, Hiroko Kanda, Kenji Namba, Hironobu Nitanai, Jason Z Zhang, Ving J Lee, William J Watkins.   

Abstract

A series of 4-oxo-4H-pyrido[1,2-a]pyrimidine derivatives, derivatized at the 2-position with aromatic substituents, were synthesized by the Suzuki cross-coupling method and evaluated for their ability to potentiate the activity of the fluoroquinolone levofloxacin (LVFX) and the anti-pseudomonas beta-lactam aztreonam (AZT) in Pseudomonas aeruginosa. By incorporating hydrophilic substituents onto the aryl nucleus, we found a morpholine analogue that possessed improved solubility, retained activity in vitro, and displayed potentiation activity in vivo in a rat model of P. aeruginosa pneumonia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979895     DOI: 10.1016/j.bmc.2006.08.037

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.

Authors:  Son T Nguyen; Steven M Kwasny; Xiaoyuan Ding; Steven C Cardinale; Courtney T McCarthy; Hong-Suk Kim; Hiroshi Nikaido; Norton P Peet; John D Williams; Terry L Bowlin; Timothy J Opperman
Journal:  Bioorg Med Chem       Date:  2015-03-13       Impact factor: 3.641

Review 3.  The hydrophobic trap-the Achilles heel of RND efflux pumps.

Authors:  Zachary Aron; Timothy J Opperman
Journal:  Res Microbiol       Date:  2017-11-13       Impact factor: 3.992

Review 4.  Optimization of a novel series of pyranopyridine RND efflux pump inhibitors.

Authors:  Zachary Aron; Timothy J Opperman
Journal:  Curr Opin Microbiol       Date:  2016-05-24       Impact factor: 7.934

Review 5.  Microbial efflux pump inhibition: tactics and strategies.

Authors:  George P Tegos; Mark Haynes; J Jacob Strouse; Mohiuddin Md T Khan; Cristian G Bologa; Tudor I Oprea; Larry A Sklar
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.

Authors:  Timothy J Opperman; Steven M Kwasny; Hong-Suk Kim; Son T Nguyen; Chad Houseweart; Sanjay D'Souza; Graham C Walker; Norton P Peet; Hiroshi Nikaido; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

7.  Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.

Authors:  Momen Askoura; Walid Mottawea; Turki Abujamel; Ibrahim Taher
Journal:  Libyan J Med       Date:  2011-05-13       Impact factor: 1.657

Review 8.  Recent advances toward a molecular mechanism of efflux pump inhibition.

Authors:  Timothy J Opperman; Son T Nguyen
Journal:  Front Microbiol       Date:  2015-05-05       Impact factor: 5.640

9.  Hexafluoroisopropyl alcohol mediated synthesis of 2,3-dihydro-4H-pyrido[1,2-a]pyrimidin-4-ones.

Authors:  Mohammad A Alam; Zakeyah Alsharif; Hessa Alkhattabi; Derika Jones; Evan Delancey; Adam Gottsponer; Tianhong Yang
Journal:  Sci Rep       Date:  2016-11-02       Impact factor: 4.379

10.  The intrinsic resistome of bacterial pathogens.

Authors:  Jorge Olivares; Alejandra Bernardini; Guillermo Garcia-Leon; Fernando Corona; Maria B Sanchez; Jose L Martinez
Journal:  Front Microbiol       Date:  2013-04-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.